Detalhe da pesquisa
1.
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
J Cancer Res Clin Oncol
; 150(4): 189, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605258
2.
Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension.
Ther Clin Risk Manag
; 15: 45-57, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636878
3.
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment.
Blood Adv
; 7(24): 7581-7584, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922425
4.
[Randomized controlled trials of needle knife therapy combined with rotation traction manipulation for the treatment of cervical spondylotic radiculopathy].
Zhongguo Gu Shang
; 29(9): 820-824, 2016 Sep 25.
Artigo
em Zh
| MEDLINE | ID: mdl-29282952
5.
Multiple myeloma with intracranial extension and bilateral renal infiltration: A case report and review of the literature.
Oncol Lett
; 10(4): 2337-2340, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26622847
6.
Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis.
Oncol Lett
; 10(4): 2403-2409, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26622860
7.
[Role of CD47 in hematologic malignancies].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 21(6): 1631-4, 2013 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-24370062